180 Life Sciences
(NASDAQ:ATNF)
180 Life Sciences Corp. - Common Stock is expected to split Monday, August 15, 2022 with a ratio of 1:5
180 Life Sciences Corp. - Common Stock recently split on Friday, August 12, 2022 with a ratio of 1:3
$1.14
0.07[6.54%]
At close: Aug 12
$1.16
0.0200[1.75%]
After Hours: 6:38PM EDT
Day High/Low1.07 - 1.19
52 Week High/Low0.79 - 4.04
Open / Close1.19 / 1.14
Float / Outstanding33.5M / 37.7M
Vol / Avg.87.4K / 264.9K
Mkt Cap43M
P/E1.41
50d Avg. Price1.14
Div / Yield-
Payout Ratio-
EPS0.05
Total Float33.5M

180 Life Sciences (NASDAQ:ATNF), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$4.00

Lowest Price Target1

$4.00

Consensus Price Target1

$48.48

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
3661511

Analyst Firms Making Recommendations1

  • Cantor Fitzgerald
  • Deutsche Bank
  • Oppenheimer
  • JP Morgan
  • Piper Sandler

1calculated from analyst ratings published within the last 6 months

Analyst Ratings for 180 Life Sciences

All Ratings (0)

Upgrades (0)

Downgrades (0)

Initiations (0)

date
Upside/Downside
Analyst Firm
Price Target Change
Rating Change
Previous / Current Rating
Get Alert

180 Life Sciences Questions & Answers

Q
What is the target price for 180 Life Sciences (ATNF)?
A

The latest price target for 180 Life Sciences (NASDAQ: ATNF) was reported by Cantor Fitzgerald on August 12, 2022. The analyst firm set a price target for $4.00 expecting ATNF to rise to within 12 months (a possible 250.88% upside). 100 analyst firms have reported ratings in the last year.

Q
What is the most recent analyst rating for 180 Life Sciences (ATNF)?
A

The latest analyst rating for 180 Life Sciences (NASDAQ: ATNF) was provided by Cantor Fitzgerald, and 180 Life Sciences initiated their overweight rating.

Q
When is the next analyst rating going to be posted or updated for 180 Life Sciences (ATNF)?
A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of 180 Life Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for 180 Life Sciences was filed on August 12, 2022 so you should expect the next rating to be made available sometime around August 12, 2023.

Q
Is the Analyst Rating 180 Life Sciences (ATNF) correct?
A

While ratings are subjective and will change, the latest 180 Life Sciences (ATNF) rating was a initiated with a price target of $0.00 to $4.00. The current price 180 Life Sciences (ATNF) is trading at is $1.14, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.